IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 24 filers reported holding IBERE PHARMACEUTICALS in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $100,000 | – | 10,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hartree Partners, LP | 1,285,000 | $12,914,250,000 | 3.01% |
| Wealthspring Capital LLC | 277,192 | $2,786,000 | 0.70% |
| BASSO CAPITAL MANAGEMENT, L.P. | 135,404 | $1,361,000 | 0.17% |
| Omni Partners US LLC | 364,371 | $3,662,000 | 0.16% |
| Sage Mountain Advisors LLC | 93,470 | $939,000 | 0.16% |
| Castle Creek Arbitrage, LLC | 253,446 | $2,540,000 | 0.14% |
| Shaolin Capital Management LLC | 396,200 | $3,982,000 | 0.12% |
| Context Capital Management, LLC | 115,053 | $1,156,000 | 0.11% |
| PERISCOPE CAPITAL INC. | 250,000 | $2,512,000 | 0.08% |
| Magnetar Financial LLC | 803,400 | $8,074,000 | 0.08% |